High-depth whole genome sequencing of premalignant breast lesions reveals rearrangement hotspots and personalized management opportunities

Journal:
Nature Communications
Published:
Affiliations:
36
Authors:
55
Institutions Authors Share
University of Cambridge, United Kingdom (UK)
14.000000
14.000000
0.25
Netherlands Cancer Institute (NKI), Netherlands
9.833333
0.18
Oslo University Hospital (OUS), Norway
3.500000
0.06
University of California, San Diego (UC San Diego), United States of America (USA)
3.000000
0.05
Lund University (LU), Sweden
2.500000
0.05
Stanford University, United States of America (USA)
2.000000
0.04
Illumina Cambridge Ltd., United Kingdom (UK)
2.000000
0.04
The University of Texas MD Anderson Cancer Center, United States of America (USA)
2.000000
0.04
Breast Cancer Association Netherlands (BVN), Netherlands
2.000000
0.04
Leiden University Medical Center (LUMC), Netherlands
1.500000
0.03
Oncode Institute, Netherlands
1.333333
0.02
Queen's University Belfast (QUB), United Kingdom (UK)
1.000000
0.02
The University of Kansas (KU), United States of America (USA)
1.000000
0.02
Patient Advocates In Research (PAIR), United States of America (USA)
1.000000
0.02
Duke University, United States of America (USA)
1.000000
0.02
DCIS411, United States of America (USA)
1.000000
0.02
University of Birmingham, United Kingdom (UK)
1.000000
0.02
Independent Cancer Patients' Voice (ICPV), United Kingdom (UK)
1.000000
0.02
Dan L. Duncan Comprehensive Cancer Center, United States of America (USA)
1.000000
0.02
Sunway University, Malaysia
0.500000
0.01
Skåne University Hospital in Lund, SUS, Sweden
0.500000
0.01
Cambridge University Hospitals NHS Foundation Trust, United Kingdom (UK)
0.500000
0.01
University of Oslo (UiO), Norway
0.500000
0.01
Guy's and St Thomas' NHS Foundation Trust, United Kingdom (UK)
0.500000
0.01
King's College London (KCL), United Kingdom (UK)
0.500000
0.01
Delft University of Technology (TU Delft), Netherlands
0.333333
0.01